Syphilis/Primary prevention
Page has default form::MedicalTherapy {{#meta: itemprop="medicalWebPageAudiences" content="patient"}}{{#meta: itemprop="medicalWebPageSpecialities" content="cardiology"}}{{#meta: itemprop="medicalWebPageInfoTypes" content="symptoms,diagnosis,treatment,causes,prognosis,complications"}}
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-In-Chief: Lakshmi Gopalakrishnan, M.B.B.S. [2]
Overview
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [3]Associate Editor(s)-in-Chief: Aysha Anwar, M.B.B.S[4]
|
Syphilis Microchapters | |
|
Diagnosis | |
|
Treatment | |
|
Case Studies | |
|
Syphilis/Primary prevention On the Web | |
|
American Roentgen Ray Society Images of Syphilis/Primary prevention | |
|
Risk calculators and risk factors for Syphilis/Primary prevention | |
Overview
There is no vaccine available for prevention of syphilis.[1][2] However, effective measures for the primary prevention of syphilis include abstinence from intimate physical contact with an infected person, consistent use of latex condoms, limiting number of sexual partners, avoidance of sharing sex toys, practising safe sex, routine screening in pregnant females, individuals with high risk behaviours, and those residing in highly prevalent areas.
Primary prevention
Effective measures for the primary prevention of syphilis include:[1][2][3]
- Abstinence from intimate physical contact with an infected person
- Consistent use of latex condoms
- Limiting number of sexual partners
- Avoid sharing sex toys
- Practicing safe sex
- Routine screening in pregnant females, individuals with high risk behaviors, and those residing in highly prevalent areas
References
- ↑ 1.0 1.1 Stamm LV (2010). "Global challenge of atibiotic-resistant Treponema pallidum". Antimicrobial Agents and Chemotherapy. 54 (2): 583–9. doi:10.1128/AAC.01095-09. PMC 2812177. PMID 19805553. Retrieved 2012-02-21. Unknown parameter
|month=ignored (help) - ↑ 2.0 2.1 Cameron CE, Lukehart SA (2014). "Current status of syphilis vaccine development: need, challenges, prospects". Vaccine. 32 (14): 1602–9. doi:10.1016/j.vaccine.2013.09.053. PMC 3951677. PMID 24135571.
- ↑ http://www.cdc.gov/std/tg2015/syphilis.htm Accessed on September 27, 2016
Related Pages
- Adverse Outcomes:
- Contraindications:
- Duplicate Therapies:
- Indications: {{:}}
- Prevents:Prevents::Syphilis
- Treats: